|
⚲
|
| Keyboard |
| Palani Santhosh
✚
|
|
|---|---|
| CIK # | 0002013475 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002013475] | |
| 4 | [0002013475] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Palani Santhosh | |
| Acrivon Therapeutics Inc | |
| Pyxis Oncology Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2026-03-24 | Grant | 45,867 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2025-06-13 | Grant | 20,275 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Grant | 36,979 | $0.98 | 36,239 |
|
Pyxis Oncology Inc PYXS
Common Stock
|
2024-06-07 | Grant | 6,000 | $0.00 | |
|
Pyxis Oncology Inc PYXS
Stock Option (Right to Buy) · derivative
|
2024-03-12 | Grant | 69,760 | $0.00 | |
|
Acrivon Therapeutics Inc ACRV
Stock Option (Right to Buy) · derivative
|
2024-03-04 | Grant | 32,500 | $0.00 |